Skip to main content


We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities:


Dear Dawei,
Dear all,
What is the time frame for the meeting?
Actually, I have 3 (!!) other meetings (ISO meetings) in parallel already, so I only could join in for short time and only later in this meeting.
Thanks and best regards,
Martin Golebiewski
Schloss-Wolfsbrunnenweg 35
69118 Heidelberg
phone +49 6221 533 281
fax +49 6221 533 298
email ***@***.***
Amtsgericht Mannheim / HRB 337446
Managing Director: Dr. Gesa Schönberger
Scientific Director: PD Wolfgang Müller
Von: im Auftrag von daweilin via RDA-COVID19-Clinical
Antworten an: “***@***.***
Datum: Dienstag, 16. Juni 2020 um 21:40
An: “***@***.***
Cc: “Jackson-Dipina, Andrea (NIH/OD) [E]” , Sergio Bonini , Anne Cambon-Thomsen , “***@***.***
Betreff: [rda-covid19-clinical] Last Clinical Subgroup call on use cases and future steps
Dear all,
We will have our last call for the subgroup, but it does not mean our work stops. We will discuss a few ideas to follow up on our recommendations and guidelines.
1. What are the use cases for our recommendations and guidelines
2. What do we want to leverage our writing so far? To develop it into a white paper or a publication?
We welcome you to join us 13.00 UTC on June 17, 2020 at or use the direct URL
Co-Moderators: Sergio Bonini (***@***.***), Andrea Jackson-Dipina (***@***.***), Dawei Lin (***@***.***), Christian Ohmann ( ***@***.*** )
Co-Chair Liaison: Anne Cambon-Thomsen (***@***.***